Next Article in Journal
The Infant Gut Microbiome: Evidence for Obesity Risk and Dietary Intervention
Next Article in Special Issue
Differential Acute Effects of Selenomethionine and Sodium Selenite on the Severity of Colitis
Previous Article in Journal
Antioxidant Activity and Nutritional Status in Anorexia Nervosa: Effects of Weight Recovery
Previous Article in Special Issue
A Review of Dietary Selenium Intake and Selenium Status in Europe and the Middle East

Biomarkers of Selenium Status

Grand Forks Human Nutrition Research Center, USDA-ARS, 2420 2nd Ave N Grand Forks, ND 58202, USA
Nutrients 2015, 7(4), 2209-2236;
Received: 27 February 2015 / Revised: 17 March 2015 / Accepted: 24 March 2015 / Published: 31 March 2015
(This article belongs to the Special Issue Dietary Selenium and Human Health)
The essential trace element, selenium (Se), has multiple biological activities, which depend on the level of Se intake. Relatively low Se intakes determine the expression of selenoenzymes in which it serves as an essential constituent. Higher intakes have been shown to have anti-tumorigenic potential; and very high Se intakes can produce adverse effects. This hierarchy of biological activities calls for biomarkers informative at different levels of Se exposure. Some Se-biomarkers, such as the selenoproteins and particularly GPX3 and SEPP1, provide information about function directly and are of value in identifying nutritional Se deficiency and tracking responses of deficient individuals to Se-treatment. They are useful under conditions of Se intake within the range of regulated selenoprotein expression, e.g., for humans <55 μg/day and for animals <20 μg/kg diet. Other Se-biomarkers provide information indirectly through inferences based on Se levels of foods, tissues, urine or feces. They can indicate the likelihood of deficiency or adverse effects, but they do not provide direct evidence of either condition. Their value is in providing information about Se status over a wide range of Se intake, particularly from food forms. There is need for additional Se biomarkers particularly for assessing Se status in non-deficient individuals for whom the prospects of cancer risk reduction and adverse effects risk are the primary health considerations. This would include determining whether supranutritional intakes of Se may be required for maximal selenoprotein expression in immune surveillance cells. It would also include developing methods to determine low molecular weight Se-metabolites, i.e., selenoamino acids and methylated Se-metabolites, which to date have not been detectable in biological specimens. Recent analytical advances using tandem liquid chromatography-mass spectrometry suggest prospects for detecting these metabolites. View Full-Text
Keywords: selenium; biomarker; status; antitumorigenesis; toxicity; selenoprotein; selenoprotein P; glutathione peroxidase; selenosugar; methylselenol selenium; biomarker; status; antitumorigenesis; toxicity; selenoprotein; selenoprotein P; glutathione peroxidase; selenosugar; methylselenol
Show Figures

Figure 1

MDPI and ACS Style

F. Combs, Jr., G. Biomarkers of Selenium Status. Nutrients 2015, 7, 2209-2236.

AMA Style

F. Combs, Jr. G. Biomarkers of Selenium Status. Nutrients. 2015; 7(4):2209-2236.

Chicago/Turabian Style

F. Combs, Jr., Gerald. 2015. "Biomarkers of Selenium Status" Nutrients 7, no. 4: 2209-2236.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop